Etoposide/ifosfamideNeutropenia and sepsis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1857卷 / 1期

关键词：

D O I：

10.1007/s40278-021-96537-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：152 / 152

相关论文

共 50 条

[21] Etoposide/trastuzumabAlopecia and febrile neutropenia: 2 case reports
Reactions Weekly, 2022, 1935 (1) : 205 - 205
[22] Carboplatin/etoposide/paclitaxelLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1938 (1) : 364 - 364
[23] Etoposide/ifosfamidePrimary lung adenocarcinoma: 2 case reports
Reactions Weekly, 2021, 1868 (1) : 191 - 191
[24] Camrelizumab/etoposide/irinotecanLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1975 (1) : 93 - 93
[25] IfosfamideNeutropenia: case report
Reactions Weekly, 2018, 1728 (1) : 183 - 183
[26] Anakinra and immunosuppressantsInfections and sepsis: 2 case reports
Reactions Weekly, 2023, 1986 (1) : 46 - 46
[27] PralsetinibSevere sepsis and typhlitis: 2 case reports
Reactions Weekly, 2023, 1959 (1) : 558 - 558
[28] Cyclophosphamide/epirubicinNeutropenic sepsis: 2 case reports
Reactions Weekly, 2021, 1875 (1) : 109 - 109
[29] InfliximabListeria monocytogenes sepsis: 2 case reports
Reactions Weekly, 2007, 1181 (1) : 20 - 20
[30] CyanoacrylateSplenic infarct and sepsis : 2 case reports
Reactions Weekly, 2024, 2020 (1) : 160 - 160

← 1 2 3 4 5 →